Elevated CEA is associated with worse survival in recurrent rectal cancer

Won Kyung Cho; Doo Ho Choi; Hee Chul Park; Won Park; Jeong Il Yu; Young Suk Park; Joon Oh Park; Ho Yeong Lim; Won Ki Kang; Hee Cheol Kim; Yong Beom Cho; Seong Hyeon Yun; Woo Yong Lee

doi:10.18632/oncotarget.22511

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Elevated CEA is associated with worse survival in recurrent rectal cancer

Won Kyung Cho, Doo Ho Choi _, Hee Chul Park, Won Park, Jeong Il Yu, Young Suk Park, Joon Oh Park, Ho Yeong Lim, Won Ki Kang, Hee Cheol Kim, Yong Beom Cho, Seong Hyeon Yun and Woo Yong Lee

PDF | HTML | How to cite

Oncotarget. 2017; 8:105936-105941. https://doi.org/10.18632/oncotarget.22511

Metrics: PDF 1648 views | HTML 3224 views | ?

Abstract

Won Kyung Cho1, Doo Ho Choi1, Hee Chul Park1, Won Park1, Jeong Il Yu1, Young Suk Park2, Joon Oh Park2, Ho Yeong Lim2, Won Ki Kang2, Hee Cheol Kim3, Yong Beom Cho3, Seong Hyeon Yun3 and Woo Yong Lee3

1Department of Radiation Oncology, Seoul, Republic of Korea

2Division of Hematology-Oncology, Department of Medicine, Seoul, Republic of Korea

3Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

Correspondence to:

Doo Ho Choi, email: [email protected]

Keywords: CEA; rectal cancer; recurrence; survival

Received: May 18, 2017 Accepted: November 03, 2017 Published: November 18, 2017

ABSTRACT

This study investigated the prognostic impact of serum carcinoembryonic antigen (CEA) level in recurrent rectal cancer. We reviewed 745 patients who developed recurrence after curative treatment for rectal cancer between January 2000 and December 2012. Multivariate analyses for survival revealed that age > 60 years (p = 0.005), r-CEA ≥ 5 ng/ml (p < 0.001), disease free interval (DFI) < 12 months (p < 0.001), and palliative or conservative treatment (p < 0.001) were unfavorable factors.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22511

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

Elevated CEA is associated with worse survival in recurrent rectal cancer

Abstract